Exploring how certain genes affect Alzheimer's disease

Uncovering the Role of the MS4A Gene Family in Alzheimer's Disease

NIH-funded research Icahn School of Medicine at Mount Sinai · NIH-10915441

This study is looking at how certain genes might affect the brain's immune system in people with Alzheimer's disease, using special techniques to learn more about how these genes work, with the hope of finding new ways to treat the condition.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionIcahn School of Medicine at Mount Sinai NIH-funded
Lab location1 site (New York, United States)
Project IDNIH-10915441 on NIH RePORTER

What this research studies

This research investigates the role of the MS4A gene family in Alzheimer's disease, focusing on how these genes may influence the brain's immune response. By using advanced techniques like CRISPR to edit human stem cells, the study aims to understand how variations in these genes affect microglial function, which is crucial for brain health. The research seeks to identify potential therapeutic targets that could lead to new treatments for Alzheimer's disease, a condition currently lacking effective interventions.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease or those diagnosed with early-stage Alzheimer's.

Not a fit: Patients with advanced Alzheimer's disease or those without genetic risk factors for the condition may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in targeting immune responses in Alzheimer's disease, suggesting that this approach may yield valuable insights.

Where this research is happening

New York, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease riskAlzheimer's disease therapeutic
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.